Correlation Between Milestone Pharmaceuticals and Assembly Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Assembly Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Assembly Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Assembly Biosciences, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Assembly Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Assembly Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Assembly Biosciences.

Diversification Opportunities for Milestone Pharmaceuticals and Assembly Biosciences

-0.24
  Correlation Coefficient

Very good diversification

The 3 months correlation between Milestone and Assembly is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Assembly Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Assembly Biosciences and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Assembly Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Assembly Biosciences has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Assembly Biosciences go up and down completely randomly.

Pair Corralation between Milestone Pharmaceuticals and Assembly Biosciences

Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 0.84 times more return on investment than Assembly Biosciences. However, Milestone Pharmaceuticals is 1.19 times less risky than Assembly Biosciences. It trades about 0.16 of its potential returns per unit of risk. Assembly Biosciences is currently generating about 0.06 per unit of risk. If you would invest  152.00  in Milestone Pharmaceuticals on August 29, 2024 and sell it today you would earn a total of  33.00  from holding Milestone Pharmaceuticals or generate 21.71% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy97.67%
ValuesDaily Returns

Milestone Pharmaceuticals  vs.  Assembly Biosciences

 Performance 
       Timeline  
Milestone Pharmaceuticals 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Milestone Pharmaceuticals are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Milestone Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
Assembly Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Assembly Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong primary indicators, Assembly Biosciences is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Milestone Pharmaceuticals and Assembly Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Milestone Pharmaceuticals and Assembly Biosciences

The main advantage of trading using opposite Milestone Pharmaceuticals and Assembly Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Assembly Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Assembly Biosciences will offset losses from the drop in Assembly Biosciences' long position.
The idea behind Milestone Pharmaceuticals and Assembly Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Bonds Directory
Find actively traded corporate debentures issued by US companies
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Volatility Analysis
Get historical volatility and risk analysis based on latest market data